News
THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conservatory-trained viola...
This is the 16th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...
Jesse Gelsinger was 18 and healthy when he died in 1999 during a gene-therapy experiment. He had a condition called...
In biotech, your company is only as good as its intellectual property. And the Supreme Court on Monday left a...
When queried about the present state of biotechnology, Kevin Esvelt tends to sound more like a science skeptic than a...
New York University’s medical school has quietly shut down eight studies at its prominent psychiatric research center and parted...
The project to understand the human genome has long promised to revolutionise the way that diseases are diagnosed, drugs are...
It is tempting to provide an alarmist answer to this question. Yet it is wise to avoid the apocalyptic tone...
LELAND -- After years of battles with the state, Elnora Mills is still waiting for a final payment from a...
CRISPR Therapeutics has raised an additional $38 million as part of its Series B raise, bringing its total...